Serologic testing of US blood donations to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–reactive antibodies: December 2019–January …

SV Basavaraju, ME Patton, K Grimm… - Clinical Infectious …, 2021 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that
causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in …

[PDF][PDF] Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Reactive Antibodies: December 2019 …

SV Basavaraju, ME Patton, K Grimm, MAU Rasheed… - scholar.archive.org
Background. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that
causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in …

Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Reactive Antibodies: December 2019 …

SV Basavaraju, ME Patton, K Grimm… - Clinical Infectious …, 2021 - search.ebscohost.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that
causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in …

[PDF][PDF] Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Reactive Antibodies: December 2019 …

SV Basavaraju, ME Patton, K Grimm, MAU Rasheed… - researchgate.net
Background. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that
causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in …

Serologic testing of US blood donations to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-reactive antibodies: December 2019-January …

SV Basavaraju, ME Patton, K Grimm, MA Ur-Rasheed… - 2021 - cabidigitallibrary.org
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that
causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in …

[PDF][PDF] Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Reactive Antibodies: December 2019 …

SV Basavaraju, ME Patton, K Grimm, MAU Rasheed… - academia.edu
Background. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that
causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in …

Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January …

SV Basavaraju, ME Patton, K Grimm… - … publication of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that
causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in …

Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January …

SV Basavaraju, ME Patton, K Grimm… - … Diseases: an Official …, 2021 - europepmc.org
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that
causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in …

[PDF][PDF] Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Reactive Antibodies: December 2019 …

SV Basavaraju, ME Patton, K Grimm… - Clinical Infectious …, 2021 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that
causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in …

[PDF][PDF] Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Reactive Antibodies: December 2019 …

SV Basavaraju, ME Patton, K Grimm… - Clinical Infectious …, 2021 - goachronicle.com
Background. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that
causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in …